文献速递胸部CT

间质性肺疾病中肺癌诊断延迟的评估

Assessment of delays in diagnosis of lung cancer in interstitial lung disease.
PubMed 文献 · Eur Radiol · 2025-09-24

这项回顾性研究纳入两家三级间质性肺疾病转诊中心的54例间质性肺疾病合并肺癌患者,由四名胸部放射科医生小组判定最早可提示结节的日期与首次临床怀疑日期,评估诊断延迟、肿瘤特征、生长速率(体积倍增时间)及生存。结果显示50%(27/54)病例存在诊断延迟,平均延迟3.18年(IQR 0.94-4.51),延迟组肿瘤生长更慢(平均体积倍增时间1.42年 vs 0.22年,p<0.0001),最常见漏诊影像因素为纤维化、磨玻璃影或支气管血管束遮挡(63%),但两组肿瘤大小、形态、分期、组织学亚型及生存无显著差异。

要点

  • 间质性肺疾病患者中约半数肺癌诊断延迟,平均延迟超过3年,需警惕外周纤维化区域缓慢生长的结节。
  • 延迟诊断最常见的影像原因是纤维化、磨玻璃影或支气管血管束遮挡病灶(63%)。
  • 延迟组肿瘤体积倍增时间更长(1.42年 vs 0.22年),但两组生存无显著差异(χ²=0.4,p=0.5)。

核心结论

  • 间质性肺疾病患者中半数肺癌诊断显著延迟,主要归因于肺实质遮挡和细微影像表现而非生物学侵袭性疾病;尽管延迟,生存结局和肿瘤特征无显著差异,提示延迟组肿瘤表型侵袭性较低。

研究设计与样本

  • 回顾性研究,纳入两家三级间质性肺疾病转诊中心的54例间质性肺疾病合并肺癌患者,由四名胸部放射科医生组成的小组判定最早可提示结节的日期并与首次临床怀疑日期比较,分析肿瘤大小、形态、分期、生长速率(体积倍增时间)、治疗方案和生存。

关键影像表现/征象

  • 延迟组平均体积倍增时间为1.42年,非延迟组为0.22年,延迟组肿瘤生长显著更慢(p<0.0001)。
  • 漏诊最常见的影像因素为纤维化、磨玻璃影或支气管血管束遮挡病灶(63%)。
  • 误判为感染或急性加重占15%,间期增长轻微占11%,CT上不可见占15%。
  • 肿瘤大小、形态、分期和组织学亚型(最常见为腺癌,56%)在延迟组与非延迟组间相似。

诊断标准与关键数值

  • 诊断延迟定义为最早可提示结节的日期(多数放射科医生会对结节提出关切)与首次临床怀疑日期之间的间隔。
  • 诊断延迟发生于50%(27/54)的病例,平均延迟3.18年(IQR 0.94-4.51)。

临床应用与阅片要点

  • 阅片时应警惕外周纤维化区域中缓慢生长的结节,避免因纤维化、磨玻璃影或支气管血管束遮挡而漏诊。
  • 注意将新发或增大的结节与感染或间质性肺疾病急性加重相鉴别,避免误判。
  • 对间期增长轻微的病灶保持随访意识,避免因增长缓慢而延误诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate diagnostic delays in lung cancer among patients with interstitial lung disease (ILD), assess tumor characteristics and outcomes, and identify radiologic factors contributing to missed or delayed detection.

MATERIALS AND METHODS: In this retrospective study, 54 ILD patients with concurrent lung cancer from two tertiary ILD referral centers were reviewed. A panel of four thoracic radiologists determined the earliest callable date-when the majority would have raised concern about a nodule-compared to the date of first clinical suspicion. Tumor size, morphology, staging, growth rate (volume doubling time), treatment regimens, and survival were analyzed. For delayed cases, radiologic causes of missed detection were categorized by consensus.

RESULTS: Diagnostic delays occurred in 50% of cases (27/54), with a mean delay of 3.18 years (IQR: 0.94-4.51). Delayed cases showed significantly slower tumor growth (mean volume doubling time: 1.42 vs. 0.22 years, p < 0.0001). The most common radiologic factors contributing to missed detection were obscuration by fibrosis, ground-glass opacity, or bronchovascular bundles (63%), misinterpretation as infection or exacerbation (15%), minimal interval growth (11%), and invisibility on CT (15%). Tumor size, morphology, stage, and histologic subtype-most commonly adenocarcinoma (56%)-were similar between groups. No significant difference in survival was observed between delayed and non-delayed cases (χ² = 0.4, p = 0.5).

CONCLUSION: Half of the lung cancer cases in ILD patients were diagnosed with significant delay, primarily due to parenchymal masking and subtle imaging findings, rather than biologically aggressive disease. Despite delays, survival outcomes and tumor characteristics did not differ significantly, suggesting a less aggressive tumor phenotype in delayed cases.

KEY POINTS: Question To evaluate diagnostic delays in lung cancer among patients with interstitial lung disease (ILD), assess tumor characteristics and outcomes, and identify radiologic factors contributing to missed or delayed detection. Findings Half of lung cancer cases in ILD patients had diagnostic delays, mainly due to parenchymal masking. Delayed cases showed slower growth but no survival difference; tumor size and histology were indifferent. Clinical relevance This study shows that lung cancer diagnosis is often delayed in ILD patients (avg. > 3 years). Clinicians should stay alert for malignancy in peripheral fibrotic regions with slow-growing nodules. Despite no clear survival impact, future work should assess the risks and benefits of earlier detection.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Schnitzler T, Nowroozi A, Vella M, et al. Assessment of delays in diagnosis of lung cancer in interstitial lung disease. Eur Radiol. 2025. PMID: 40990985. doi:10.1007/s00330-025-12015-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。